Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax RateTax Rate
Others
Ratios

Exagen (XGN) Profit After Tax (2018 - 2026)

Exagen filings provide 9 years of Profit After Tax readings, the most recent being -$4.0 million for Q1 2026.

  • On a quarterly basis, Profit After Tax fell 5.73% to -$4.0 million in Q1 2026 year-over-year; TTM through Mar 2026 was -$20.2 million, a 30.04% decrease, with the full-year FY2025 number at -$20.0 million, down 31.99% from a year prior.
  • Profit After Tax hit -$4.0 million in Q1 2026 for Exagen, up from -$4.7 million in the prior quarter.
  • In the past five years, Profit After Tax ranged from a high of -$3.0 million in Q2 2024 to a low of -$14.7 million in Q2 2022.
  • Median Profit After Tax over the past 5 years was -$5.0 million (2024), compared with a mean of -$6.5 million.
  • Biggest five-year swings in Profit After Tax: crashed 128.78% in 2022 and later surged 65.82% in 2023.
  • Exagen's Profit After Tax stood at -$14.4 million in 2022, then soared by 61.17% to -$5.6 million in 2023, then soared by 32.51% to -$3.8 million in 2024, then fell by 24.25% to -$4.7 million in 2025, then increased by 15.11% to -$4.0 million in 2026.
  • The last three reported values for Profit After Tax were -$4.0 million (Q1 2026), -$4.7 million (Q4 2025), and -$7.1 million (Q3 2025) per Business Quant data.